Methods and compositions for detection of
View Patent ↗Methods of detecting Mycobacterium avium complex (MAC) organisms using in vitro nucleic acid amplification with amplification oligonucleotides specific for 16S rRNA or DNA sequences encoding 16S rRNA from MAC species are disclosed. Compositions and kits containing oligonucleotides for amplifying and detecting 16S rRNA or DNA sequences encoding 16S rRNA from MAC species are disclosed.
1. A combination of at least two oligonucleotides selected from the group consisting of:
a base sequence consisting of SEQ ID NO: 1 (GAAATTAATACGACTCACTATAGGGAGACCACACCCGTAGGAGTCTGGGCCGTATCTCA) or
a base sequence consisting of SEQ ID NO: 4 (CCCGTAGGAGTCTGGGCCGTATCTCA) or its completely complementary sequence, and
a base sequence consisting of SEQ ID NO: 7 (GCAAGTCGAACGGAAAGGCCTCTTCGGAGGTA) or its completely complementary sequence.
2. The combination of oligonucleotides according to claim 1 , wherein the two oligonucleotides are:
a base sequence consisting of SEQ ID NO: 1, and
a base sequence consisting of SEQ ID NO: 7 and its completely complementary sequence.
3. The combination of oligonucleotides according to claim 1 , wherein the two oligonucleotides are:
a base sequence consisting of SEQ ID NO: 4 or its completely complementary sequence, and
a base sequence consisting of SEQ ID NO: 7 and its completely complementary sequence.
4. The combination of claim 1 , further comprising at least one labeled oligonucleotide having a base sequence completely complementary to a sequence contained in a sequence that is amplified by using the combination of oligonucleotides having sequence of SEQ ID NO: 1 and SEQ ID NO: 7 or SEQ ID NO: 4 and SEQ ID NO: 7.
5. A kit containing at least one oligonucleotide selected from the group consisting of:
a base sequence consisting of SEQ ID NO: 1 (GAAATTAATACGACTCACTATAGGGAGACCACACCCGTAGGAGTCTGGGCCGTATCTCA) or
a base sequence consisting of SEQ ID NO: 4 (CCCGTAGGAGTCTGGGCCGTATCTCA) or its completely complementary sequence, and
a base sequence consisting of SEQ ID NO: 7 (GCAAGTCGAACGGAAAGGCCTCTTCGGAGGTA) or its completely complementary sequence.
6. The kit of claim 5 , further containing one or more labeled oligonucleotides having a base sequence complementary to a sequence contained in a sequence that is amplified by using a combination of oligonucleotides that are:
a base sequence consisting of SEQ ID NO: 1, and
a base sequence consisting of SEQ ID NO: 7 and its completely complementary sequence.
7. The kit of claim 5 , further containing one or more labeled oligonucleotides having a base sequence complementary to a sequence contained in a sequence that is amplified by using a combination of oligonucleotides that are:
a base sequence consisting of SEQ ID NO: 4 or its completely complementary sequence, and
a base sequence consisting of SEQ ID NO: 7 and its completely complementary sequence.
8. The kit of claim 5 , wherein the oligonucleotide is a base sequence consisting of SEQ ID NO: 1.
9. The kit of claim 5 , wherein the oligonucleotide is a base sequence consisting of SEQ ID NO: 4 or its completely complementary sequence.
10. The kit of claim 5 , wherein the oligonucleotide is a base sequence consisting of SEQ ID NO: 7 or its completely complementary sequence.
11. The kit of claim 5 , further containing at least one unlabeled helper oligonucleotide.
12. A method of detecting Mycobacterium avium complex (MAC) species present in a biological sample, comprising the steps of:
providing a biological sample containing a nucleic acid from at least one MAC species selected from the group consisting of M. tuberculosis, M. avium, M Intracellulare , and M. paratuberculosis , the nucleic acid comprising 16S ribosomal RNA (rRNA) or DNA encoding 16S rRNA;
amplifying the 16S rRNA or DNA encoding 16S rRNA in an in vitro nucleic acid amplification mixture comprising at least one polymerase activity, and at least one first primer consisting of the sequence of SEQ ID NO: 1, or the sequence of SEQ ID NO: 4 or its completely complementary sequence, and at least one second primer consisting of the sequence of SEQ ID NO: 7 or its completely complementary sequence, to produce an amplified nucleic acid; and detecting the amplified nucleic acid.
13. The method of claim 12 , wherein the detecting step comprises hybridizing the amplified nucleic acid to at least one probe and detecting a signal resulting from the amplified nucleic acid that is hybridized to the probe.
14. The method of claim 12 , wherein the detecting step uses at least one labeled probe.
15. The method of claim 12 , further comprising the step of using at least one capture oligonueleotide that specifically hybridizes to nucleic acid from at least one MAC species to bind the nucleic acid from the MAC species to an immobilized nucleic acid, to purify the nucleic acid from the MAC species from other components in the sample before the amplifying step.
16. The method of claim 12 , wherein the amplifying step amplifies 16S rRNA from M tuberculosis, M avium, M intracellulare, M paratuberculosis or any combination thereof.
17. The method of claim 12 , wherein the amplifying step uses a combination of the first primer consisting of SEQ ID NO: 1, and the second primer consisting of SEQ ID No: 7 or its completely complementary sequence.
18. The method of claim 12 , wherein the amplifying step uses a combination of the first primer consisting of SEQ ID NO: 4 or its completely complementary sequence and the second primer consisting of SEQ ID No: 7 or its completely complementary sequence.